IRCT20230409057859N1
Not yet recruiting
Phase 3
Investigating the effect of L-arginine on patients with non-alcoholic fatty liver disease
Overview
- Phase
- Phase 3
- Status
- Not yet recruiting
- Enrollment
- 60
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to no limit (—)
- Sex
- All
Inclusion Criteria
- •Patients with non\-alcoholic fatty liver
- •Patients over 18 years old
Exclusion Criteria
- •pregnant women
- •Patients with liver cirrhosis
- •Patients with viral and autoimmune hepatitis
- •Patients with advanced heart and kidney diseases
- •Patients with celiac disease
- •Wilson's patients
Investigators
Similar Trials
Completed
Phase 3
Investigating the effectiveness of L-arginine in reducing duration of hospitalization and pain intensity of children with sickle cell disease compared to placebo.Sickle cell disease.Other sickle-cell disorders with crisisD57.81IRCT20170112031891N2Ahvaz University of Medical Sciences120
Active, not recruiting
Phase 1
Pharmacological intervention study with L-arginin in prevention of diabete type II in patients affected by metabolic syndrome.EUCTR2005-004639-24-ITOSPEDALE S. RAFFAELE294
Completed
Phase 3
Investigation of the effect of oral L-arginine on pulmonary hypertension in patients with thalassemia majorIRCT20191218045785N1Shahre-kord University of Medical Sciences50
Recruiting
Phase 3
Effect of arginine on chronic anal fissureIRCT20190712044182N1Iran University of Medical Sciences76
Completed
Not Applicable
The Effect of L-arginine in the treatment of Sickle Cell Anemiasickle cell anemiaD57.1C15.378.071.141.150.150RBR-2t56nzniversidade Federal do Ceará